US Patent Issued to aTyr Pharma on Dec. 9 for "Histidyl-tRNA synthetase-Fc conjugates and therapeutics using the same" (California Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,392, issued on Dec. 9, was assigned to aTyr Pharma Inc. (San Diego).

"Histidyl-tRNA synthetase-Fc conjugates and therapeutics using the same" was invented by Chi-Fang Wu (San Diego), Darin Lee (San Diego), Jeffry D. Watkins (Encinitas, Calif.), Kristi Piehl (San Diego), Kyle Chiang (Cardiff, Calif.), Marc Thomas (Vista, Calif.), Minh-Ha Do (San Diego), Ying Buechler (Carlsbad, Calif.) and John D. Mendlein (Encinitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides histidyl-tRNA synthetase and Fc region conjugate polypeptides (HRS-Fc conjugates), such as HRS-Fc fusion polypeptides, compositions comprising the same,...